|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 12 September 2006
doi: 10.1242/jcs.03103
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
1 California Pacific Medical Center Research Institute, 475 Brannan Street, Suite 217, San Francisco, CA 94107, USA
2 Howard Hughes Medical Institute, Department of Physiology and Biophysics, University of Iowa College of Medicine, Iowa City, IA 52242, USA
3 Division of Life Sciences, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
* Author for correspondence (e-mail: Muschler{at}cpmcri.org)
Accepted 15 June 2006
| Summary |
|---|
|
|
|---|
Key words: Dystroglycan, Laminin, Polarity, Mammary, Epithelial, Integrin
| Introduction |
|---|
|
|
|---|
DG is a heterodimeric glycoprotein encoded by a single gene (DAG1) and is located on cell surfaces in most adult tissues (Michele and Campbell, 2003
). It consists of a transmembrane ß-subunit of 43 kDa and a non-covalently associated, extracellular
-subunit of 120-200 kDa (Fig. 1A). The cytoplasmic domain possess known signaling motifs and links to the actin cytoskeleton, whereas the extracellular domain is capable of interacting with extracellular matrix (ECM) proteins, such as laminins, agrin and perlecan (Michele and Campbell, 2003
). Binding of DG to laminin-111 occurs at the C-terminal laminin G-like (LG) globular domains LG4 and LG5 of the laminin
subunit (Ervasti and Campbell, 1993
; Gee et al., 1993
) (Fig. 1B). In skeletal muscle, DG serves as a transmembrane link between laminin-2 in the ECM and the intracellular actin cytoskeleton, possibly stabilizing the muscle-cell membrane (Ervasti and Campbell, 1993
). In such cells, DG forms part of the dystrophin-glycoprotein complex and certain defects in these components result in distinct muscular dystrophies (Durbeej and Campbell, 2002
).
|
Several studies have implicated DG in BM-induced epithelial functions, consistent with its location on the basolateral surface of epithelial cells contacting the BM, including those in the mammary gland (Durbeej et al., 1998
). Based on antibody perturbation studies, DG plays a role in epithelial morphogenesis in kidney, lung, and salivary gland (Durbeej et al., 1995
; Durbeej et al., 2001
). Genetic disruption of DG expression revealed functions in survival of Drosophila epithelial cells (Deng et al., 2003
) and epiblasts of embryoid bodies (Li et al., 2002
). DG has also been implicated in epithelial polarity by a study in Drosophila (Deng et al., 2003
) and by overexpression in a tumorigenic human MEC line (Muschler et al., 2002
).
Since DG knockout in mice is embryonic lethal (Williamson et al., 1997
), DG functions have not been assessed by genetic deletion in adult mammalian epithelial cells. Here, we have used a genetic approach in cultured cells to investigate the contribution of DG to laminin-111-induced epithelial architecture and function. We examined the effect of a DG gene deletion on laminin assembly and laminin-111-induced responses in adult mouse MEC lines. Results presented here demonstrate for the first time that DG serves as a crucial MEC co-receptor mediating cell responses to the BM that include epithelial polarization and ß-casein induction. We also dissect the crucial receptor domains and present evidence that DG enacts these signals solely by anchoring laminin-111 to the cell surface, thereby facilitating laminin-111 polymerization and subsequent signaling.
| Results |
|---|
|
|
|---|
Both MEpG and MEpL cell lines were epithelial in nature, as judged by tightly packed, cobblestone-like morphologies and expression of typical MEC markers; immunodetection revealed expression of epithelial ZO-1, E-cadherin, and keratin 8 (supplementary material Fig. S1, left panel), but not myoepithelial smooth muscle
-actin or vimentin (data not shown). The normal complement of adhesion molecules, including DG,
6 and ß1 integrins was also confirmed by immunodetection (below and data not shown). The MEpG cell line was used for laminin assembly and polarity assays; these cells did not express ß-casein. The MEpL cell line was used for laminin assembly and ß-casein assays, but not for polarity analyses. Many MEpL colonies produced pseudopod-like extensions when grown in 3D matrices, making assessment of polarization difficult.
Infection of the MEpG cell line with control adenovirus produced a control DG+/+ cell population which retained expression of DG protein over time, as shown by western blotting (Fig. 1C) and immunostaining (Fig. 1D) for
-DG and ß-DG. Parallel infection of the MEpG cell line with Cre-recombinase-expressing adenovirus, to produce a DG-/- cell population, resulted in a near complete loss of DG protein expression, as demonstrated by western blotting for
-DG and ß-DG (Fig. 1C). Immunostaining revealed that about 90% of the Cre-infected MECs lacked
-DG and ß-DG expression (Fig. 1D). Similar results were obtained upon adenoviral infection of the MEpL cell line (supplementary material Fig. S2). DG+/+ and partial-DG-/- cell populations retained the epithelial marker expression profile seen in MEpG and MEpL parent cell lines prior to adenoviral exposure, showing that neither viral infection nor DG loss altered the epithelial phenotype (supplementary material Fig. S1 and data not shown).
DG loss and MEC polarity
To investigate the role of DG in laminin-111-induced MEC polarization, DG+/+ and partial-DG-/- cell populations were grown in 3D matrices containing collagen-1 with or without laminin-111, established culture models that can mimic the in vivo MEC response to the BM microenvironment. Polarity was assessed by examining the distribution of ZO-1,
6 integrin, nuclei and cytoskeletal actin.
Immunofluorescent staining of DG+/+ and DG-/- colonies grown in collagen I revealed a random distribution of nuclei, ZO-1 and
6 integrin (Fig. 2A, upper panel). Actin and DG (the latter in DG+/+ cells only) showed apolar patterns similar to
6 integrin (Fig. 2B, upper panel). Quantification of polarization using ZO-1 staining revealed few polar DG+/+ or DG-/- colonies in collagen I (Fig. 2C).
|
When laminin-111, a known inducer of polarization of mammary gland acini, was added to the collagen I matrix, DG+/+ cells polarized, displaying dramatic changes in the distribution of polarity markers and the cytoskeleton (bottom left images in Fig. 2A,B). ZO-1 and actin were found at the center of colonies, consistent with apical formation of tight junctions and an underlying cytoplasmic actin belt. DG and
6 integrin were localized basolaterally on cell surfaces and nuclei shifted to the colony periphery. Quantification using ZO-1 staining revealed a significant increase in polarized colonies in collagen-I-laminin-111 compared with collagen I alone (35.3% vs 8.0%, P<0.01; Fig. 2C).
Unlike DG+/+ cells, DG-/- cells did not significantly polarize in collagen-I-laminin-111 (bottom right images in Fig. 2A,B), exhibiting polarization levels similar to those seen in collagen I (Fig. 2C). Increasing laminin-111 from 35 µg to 75 µg in the collagen matrix did not elevate polarization of DG+/+ or DG-/- cells further (data not shown). The inability of DG-/- cells to polarize in response to laminin-111 was not due to a problem in tight-junction formation because ZO-1 still localized at cell-cell contacts in confluent monolayers of DG-/- cells grown on plastic (supplementary material Fig. S1, right panel, middle).
DG links laminin assembly and MEC polarity
DG has been implicated in laminin assembly in a few cell types (Colognato et al., 1999
; Henry and Campbell, 1998
; Williamson et al., 1997
), but such a role in differentiated epithelial cells has not been investigated. To test the hypothesis that DG-/- MECs failed to polarize in response to laminin-111 because of laminin-assembly defects, DG+/+ and DG-/- cells in 3D polarity assays were immunostained using a polyclonal antibody raised against EHS (Engelbreth-Holm-Swarm) laminin subunits.
Apolar DG+/+ cells in collagen I showed punctate patterns of endogenously produced laminin on the outer surfaces of colonies (Fig. 3A, left of top panel) that co-localized with DG in many regions (Fig. 3B, top panel). Apolar DG-/- cells in collagen I lacked laminin surface staining (Fig. 3A, right of top panel). Importantly, in collagen-I-laminin-111 gels, polarized DG+/+ cells had an extensive laminin network on the outer surfaces of colonies (Fig. 3A, left of third panel) that colocalized with DG as a more continuous array than seen in collagen I alone (Fig. 3B, bottom panel). By contrast, apolar DG-/- cells in collagen-I-laminin-111 were deficient in laminin surface staining (Fig. 3A, right of third panel).
|
To determine whether the observed lack of laminin staining on DG-/- cells was unique to the 3D ECM environment, laminin assembly was examined further using cell monolayers. Staining of DG+/+ cells for endogenous laminins revealed a diffuse, intracellular component and a punctate, extracellular pattern (Fig. 4A, left images above line). By contrast, cells lacking DG in the partial-DG-/- cell population exhibited intracellular, but not extracellular, laminin staining (Fig. 4A, right images above line). Laminin locations were confirmed by using unpermeabilized cells where only extracellular laminin staining was visible due to lack of intracellular access by the anti-laminin antibody (Fig. 4A, images below line).
|
These findings demonstrate that DG-/- cells retain the ability to synthesize laminin, but are unable to bind endogenous laminins or exogenous laminin-111 either in monolayers or within a 3D matrix. Hence, DG serves as the crucial link between laminin-111 interaction with MECs and subsequent induction of polarization in a 3D environment.
To test whether DG and integrins cooperate in laminin assembly in MECs, we employed antibodies that block integrin function. DG+/+ cells were exposed to laminin-111-FITC for 24 hours, a time at which extensive polymerization had occurred (Fig. 4C, left panel). Blocking of
6 integrins had no effect on laminin-111 assembly (Fig. 4C, second panel from left). However, inhibition of ß1 integrins diminished the extent of laminin-111 polymerization, but still allowed laminin cell-surface binding (Fig. 4C, third panel from left). This pattern was similar to that seen when DG+/+ cells were incubated with non-polymerizing laminin-111 and immunostained for laminin (Fig. 4C, insets in third panel from left). This laminin was generated by treatment with the serine protease inhibitor p-aminoethylbenzene-sulfonyl fluoride (AEBSF) (Colognato et al., 1999
). Inclusion of both
6-integrin- and ß1-integrin-blocking antibodies produced a result similar to that seen with the ß1 antibody alone (Fig. 4C, right panel). These findings indicate that DG and ß1 integrins cooperate in laminin-111 assembly on MECs, with DG serving as the initial binding site, enabling ß1 integrins to participate in subsequent polymerization and signaling.
Chimeric MEC colonies do not polarize
Cues for epithelial polarization originate from the BM and neighboring cells (Yeaman et al., 1999
). To determine whether DG influences polarization of neighboring cells, and the minimal number of DG expressors required for colony polarization, we analyzed the polarity of chimeric colonies containing both DG+/+ and DG-/- cells. Such colonies were produced in polarity assays using the partial-DG-/- MEpG population, which contained a subpopulation of DG+/+ cells (Fig. 1). Growth of cells within the 3D matrix led to a non-random distribution of DG+/+ and DG-/- cells in the final chimeric colonies. Staining of chimeric colonies in collagen-I-laminin-111 for actin and
6 integrin revealed an apolar phenotype, even when half or more of the cells in the colony were DG+/+ (Fig. 5A). Quantification using
6 integrin staining showed minimal levels of overall polarization in chimeric colonies, even when the majority of cells in a colony were DG-expressing (data are given as the mean ± s.d. and were 0.98±1.34%; n=5 counts x 40 colonies per count). Interestingly, laminin staining was visible only on the surface of DG+/+ cells, where it co-localized with DG in an extensive reticular network (Fig. 5B,C). These observations suggest that global DG expression in MEC colonies is essential for laminins to assemble around the entire colony and trigger cooperative participation of all cells in colony polarization.
|
DG loss disrupts ß-casein production in MECs
Previous results indicated that BM-induced ß-casein expression in MECs required ß1 integrins,
6ß4 integrin, and a laminin receptor binding the LG4 and LG5 domains (Faraldo et al., 1998
; Muschler et al., 1999
; Streuli et al., 1991
). To determine directly the role of DG in laminin-111-induced ß-casein production, DG+/+ and partial-DG-/- MEC populations (derived from the MEpL cell line) were tested in ß-casein assays using lactogenic hormones and a laminin-111 overlay (Streuli et al., 1995
).
DG+/+ and the partial-DG-/- cell populations produced ß-casein protein in response to laminin-111 in the presence, but not absence, of lactogenic hormones, as expected (Fig. 6A). However, the partial-DG-/- cell population showed a drastic reduction in laminin-111-induced ß-casein levels. As expected, no ß-casein was detected in either cell population upon omission of the laminin-111 overlay (Fig. 6A).
|
The DG extracellular domain alone is crucial to laminin assembly
The ß-subunit of DG contains cytoplasmic sites potentially recognized by SH3, SH2 and WW domain proteins (Ibraghimov-Beskrovnaya et al., 1992
; Pawson, 2004
). To investigate whether DG plays an active signaling role in MEC functions, three deletion mutants of the ß-DG cytoplasmic domain (DEL A, B and C) were generated and tested (supplementary material Fig. S3). DEL A lacked the entire cytoplasmic domain, except for six amino acids beyond the transmembrane region. DEL B had an internal deletion resulting in retention of the C-terminal 15 amino acids and proximal removal of several potential WW, SH3 and SH2 domain protein recognition sites. DEL C lacked the C-terminal 15 amino acids, which contain proven interaction sites for SH3-, SH2- and WW-domain proteins (Ilsley et al., 2002
; Sotgia et al., 2001
; Yang et al., 1995
).
We generated a pure DG-/- cell line (entirely lacking DG protein expression) by single-cell cloning from the partial-DG-/- MEpG cell population and then infected the DG-/- cell line with either empty retroviral vector (VEC) or vector encoding full-length DG (wtDG), DEL A, DEL B, or DEL C. Western blots showed that VEC cells were deficient in
- and ß-DG protein (Fig. 7A, left panels), whereas the other infected cells expressed
-DG protein the same size as DG+/+ cells (Fig. 7A, upper left panel). An N-terminal ß-DG antibody verified expression of the full-length ß-subunit in wtDG cells and truncated versions in DG-mutant cells (Fig. 7A, upper right panel). A ß-DG antibody recognizing an epitope in the C-terminal 15 amino acids detected the ß-subunit in wtDG and DEL B cells, but not in DEL A or C cells, verifying the lack of this epitope in the latter two populations (Fig. 7A, middle left panel).
|
-DG was correctly localized to the surface of cells infected with wtDG or DG mutant (wtDG and DG-mutant cells, respectively), and was not detected in cells infected with the empty retroviral vector (VEC cells) (Fig. 7B). Laminin-111-FITC is bound and assembled at the surface of wtDG cells but not VEC cells, showing that DG re-expression corrected the laminin assembly defects (Fig. 7C). All DG-mutant cells also assembled cell surface laminin-111-FITC comparable to wtDG cells, revealing that, surprisingly, DG cytoplasmic domains were not required (Fig. 7C). Identical results were obtained upon expression of wtDG or DG mutants in DG-/- cells derived from the MEpL cell line (data not shown).
Analysis of laminin-111-induced polarity in VEC, wtDG and DG-mutant cells demonstrated very few polar colonies in collagen I (Fig. 8A, top panel; 8B). Addition of laminin-111 to the collagen-I gel resulted in significant increases in the number of polar colonies for all but the DG-/- (VEC) cells (Fig. 8A, middle panel; 8B). In addition, immunostaining revealed laminin localization on colony surfaces of all but VEC cells grown in collagen-I-laminin-111 (Fig. 8A, bottom panel). Likewise, laminin-111-induced ß-casein levels were restored in wtDG and DG-mutant cells compared with VEC cells (Fig. 9). However, even in the complete absence of DG expression, low levels of ß-casein were seen in VEC cells treated with laminin-111. As in Fig. 6A, no ß-casein was detected in any of the cell populations in the absence of a BM overlay.
|
|
cleaving enzyme (TACE) (Moss et al., 1997
|
| Discussion |
|---|
|
|
|---|
|
Role of DG in laminin assembly
Although most laminins self-assemble spontaneously, the process is facilitated by interaction with cell surface receptors. This mechanism involves receptor binding of monomeric laminin through its C-terminal G domain and laminin polymerization through resultant interactions between neighboring N-terminal short arms (Colognato et al., 1999
). This polymerization is crucial for recruitment of other BM proteins, cytoskeletal reorganization and signaling events (Colognato et al., 1999
).
Data presented here demonstrate in an adult epithelial cell type (MECs) that DG is essential for receptor-facilitated laminin anchoring and assembly, with possible cooperation from ß1 integrins at the level of assembly. These results help to explain BM defects seen upon DG reduction or loss in brain cells, Reichert's membrane, and Drosophila epithelia (Deng et al., 2003
; Michele et al., 2002
; Moore et al., 2002
; Williamson et al., 1997
). They also support observations made using embryonic stem cells cultured in monolayer (Henry and Campbell, 1998
; Henry et al., 2001b
; Lohikangas et al., 2001
). However, the requirement for DG in laminin-BM assembly may be tissue-specific. In one study, assays for BM assembly in ES-derived embryoid bodies show no BM defects in DG-/- embryoid bodies, but show a dramatic loss of epiblast cell survival (Li et al., 2002
), although another study shows loss of laminin and BM assembly in DG-/- embryoid bodies produced by a method that did not generate a differentiated epiblast layer (Henry and Campbell, 1998
). In addition, normal BMs are observed upon DG loss in skeletal muscle and some embryonic tissues (Cohn et al., 2002
; Michele et al., 2002
; Williamson et al., 1997
). In Schwann cells and fibroblasts, certain sulfated glycolipids can mediate laminin-BM assembly (Li et al., 2005
), raising the possibility that DG and sulfated glycolipids functionally overlap.
Because DG can mediate laminin assembly and signaling in the absence of endogenous transmembrane and cytoplasmic signaling domains, and also function in the presence of a large internal deletion of the extracellular domain, it appears that laminin anchoring to the cell surface is the main role for DG in the initiation of assembly and signaling. This model is consistent with observations in fibroblasts and Schwann cells showing that laminin binding to cell-surface glycolipids is also sufficient to initiate assembly and signaling (Li et al., 2005
). Importantly, no exogenous laminin-111 binding was observed at the surface of DG-/- cells, demonstrating that no other molecule compensated for the role of DG in laminin anchoring to MECs. This result also suggests that co-receptors, such as the ß1 integrins, require the interaction of DG with laminin-111 prior to recruitment and/or activation. A recent study in intestinal epithelial cells reported direct interaction of DG and ß1 integrins by co-immunoprecipitation (Driss et al., 2005
), something we have not yet observed in MECs. This same study also reported an enhancement of integrin-laminin-111 interactions that is dependent on DG cytoplasmic sequences, but this observation is inconsistent with our results in MECs, where deletion of DG cytoplasmic sequences did not perturb function.
DG mediates signals for epithelial architecture and function
Our results show that DG also plays an essential role in mediating laminin-111-induced MEC functions, including tissue architecture and tissue-specific gene expression. DG-/- cells failed to polarize and showed markedly reduced ß-casein production because of defects in laminin-111 binding. In addition, our finding that laminin-111 and DG signaling pathways linked to polarity and ß-casein levels were independent of the ß-DG cytoplasmic domain suggests that the functional coupling of DG with co-receptors enacts signaling. Candidate co-receptors include
6ß4 or ß1 integrins that influence polarity (Faraldo et al., 1998
; Slade et al., 1999
; Weaver et al., 1997
) and ß-casein levels (Faraldo et al., 1998
; Muschler et al., 1999
; Streuli et al., 1991
). A partial, albeit weak, receptor compensation for DG loss was seen in laminin-111-induced ß-casein assays, suggesting that, in the presence of high laminin-111 levels, some spontaneous laminin self-assembly may take place, or interaction with a less effective laminin receptor may occur. Whatever the case, DG is still needed as a laminin-111 co-receptor to allow efficient ß-casein production.
The results reported here provide a molecular mechanism to explain why overexpression of DG is capable of reverting and normalizing breast tumor cells, and why the functional status of DG correlates strongly with a tumor cells ability to polarize (Muschler et al., 2002
). In addition, they explain the observed requirement for multiple MEC receptors in ß-casein expression, including a receptor for the laminin LG4-5 domain that is likely to be DG (Muschler et al., 1999
; Streuli et al., 1995
). They explain the loss of ß-casein expression upon siRNA knockdown of DG in HC-11 cells (Sgambato et al., 2006
). The results can also explain the role of DG in establishing Drosophila epithelial polarity (Deng et al., 2003
). However, DG knockout in mouse embryoid bodies does not affect polarization of epiblast cells (Li et al., 2002
), demonstrating that DG is not universally required for polarity in mammalian cells. Epiblast differentiation and polarization are affected in mice lacking the laminin
1 LG4 and LG5 modules, hinting at the existence of other receptors for these modules (Scheele et al., 2005
).
Our observation that MEC chimeras, composed of DG+/+ and DG-/- cells, did not polarize, stresses the importance of laminin assembly along the entire basal epithelial surface to establish normal tissue architecture; loss of laminin assembly on even a minority of cells is sufficient to disrupt polarity in the entire acinar structure. This result illustrates the required integration of both cell-cell and cell-BM interactions to establish cellular and tissue polarity (Yeaman et al., 1999
). DG-/- cells of chimeric colonies lacked the ability to bind surface laminin-111 and did not receive the necessary external BM cue for activation of intracellular polarity pathways, which include the establishment of proper cell-cell junctions. Consequently, with direct contact of DG+/+ and DG-/- cells, the defect of the DG-/- cells was dominant.
Significance of DG in vivo and in disease
Our findings have important implications for understanding the abnormal behavior of carcinomas of the breast and other tissues. In breast, prostate and colon cancers, loss in DG detection correlates with tumor progression (Henry et al., 2001a
; Sgambato et al., 2003
). In many carcinoma cell lines, including those of the breast, DG lacks laminin binding ability because of glycosylation changes and/or proteolytic processing (Losasso et al., 2000
; Muschler et al., 2002
; Singh et al., 2004
). Our results reveal that localized disruption of the DG-laminin-111 link in MECs leads to losses in laminin-111-induced responses important to normal epithelial architecture and function, with impact on neighboring cells as well. Thus, loss of DG function is a plausible and attractive explanation for some of the aberrant cell responses to the BM that are evident in cancer progression.
| Materials and Methods |
|---|
|
|
|---|
Generation of DG+/+ and partial-DG-/- mouse MEC populations
Adenoviral vectors (Microbix) were amplified twice in QBI-293 packaging cells (Quantum Biotechnologies), grown in DMEM (Invitrogen), 2 mM Gln, 10% FBS, and 10 µg/ml gentamicin. Immortalized floxed DG mouse MEC lines (MEpG, MEpL) were infected with either control (Ad.floxlacZ1) or Cre-recombinase-expressing (Ad.creM1) adenoviral supernatants with multiplicity of infection of 40-50.
Expression of full-length DG and mutants in pure DG-/- MEC lines
Human DG coding sequence was subcloned from pLXSN vector (Muschler et al., 2002
) into the EcoRI site of the retroviral expression vector, pBMN-IRES-PURO (Kinoshita et al., 1997
). From this construct, ß-DG cytoplasmic deletion mutants were constructed using the QuikChange XL site-directed mutagenesis kit (Stratagene) and verified by sequencing. DEL A, B, C, D, and E lacked amino acids 780-895, 806-880 and 881-895, 315-485, and 400-485, respectively (Fig. S3). DG-tmf was constructed from the ligation of two PCR products spanning amino acids 1-739 of DG and amino acids 656-699 of the human TNF-
cleaving enzyme (TACE) gene. The reverse primer for the TACE PCR product included the coding sequence for ten additional amino acids at the C-terminus (LDEESILKQE), representing the Myc tag. Retrovirus was generated using Phoenix-ECO packaging cells grown in DME/H21 (UCSF Cell Culture Facility) and 10% FBS, and transfected using calcium phosphate (Sambrook et al., 1989
).
DG-/- clones were obtained by limiting dilution of partial-DG-/- MEC populations and screened by immunostaining for lack of DG expression. Clones were seeded in 100-mm dishes, infected with 2 ml of retroviral supernatant, 6 ml of complete media, and 8 µg/ml polybrene, and selected in complete media with 5-10 µg/ml puromycin (Sigma).
3D polarity assays
Trypsinized cells (between 104 and 105 cells) were added to 300 µl of collagen I (Cellagen; ICN Biomedicals) or collagen-I-laminin-111 (35 µg; Sigma) on ice. Matrices were solidified at 37°C and covered with complete media that was changed every 2 days. On days 6 or 7, samples were immunostained. For polarity quantification, colonies with >3 nuclei were considered polar if ZO-1 staining was centrally located within the colony. For statistical analysis, comparisons between groups were subject to one-way analysis of variance and differences between means were determined using Fisher's least significant difference method.
ß-casein and laminin assembly assays
ß-casein assays were performed as previously described (Muschler et al., 1999
), except that 5 µg/ml prolactin and serum-free complete media were used. To assess laminin assembly, laminin-111-FITC was prepared by dialysing laminin-111 (Sigma) in PBS, 10 µM CaCl2, and incubating with NHS-fluorescein (Pierce) for 2 hours at 4°C in the dark. Dialysis was repeated, and laminin-111-FITC was measured by the Lowry protein assay (Peterson, 1977
). Laminin-assembly results observed using lammin-111-FITC were identical to results obtained by immunostaining for laminins after addition of unlabeled laminin-111 (data not shown). Laminin-111 was treated with p-aminoethylbenzene-sulfonyl fluoride (AEBSF) (Calbiochem) as described (Colognato et al., 1999
). Cells grown on Lab-Tek II CC2 glass chamber slides (Nalge Nunc) were immunostained following incubation at 37°C in the dark, in serum-free complete media with 10 nM AEBSF-treated laminin-111 for 24 hours or 10 nM laminin-111-FITC for 4 or 24 hours (the latter with or without antibodies that block integrin function).
Immunofluorescent staining
Cells grown on Lab-Tek II CC2 glass chamber slides (Nalge Nunc) or in 3D polarity assays were washed twice in PBS. Some 3D samples were digested with 0.2% collagenase A in complete media at 37°C to remove matrix for easier counting. For actin-
6-integrin, DG and laminin staining, samples were fixed in 2% formaldehyde in PBS for 10 minutes at room temperature, and washed in PBS, 25 mM glycine for 3x10 minutes. For ZO-1-
6-integrin staining, samples were fixed in acetone-methanol (1:1) at -20°C for 5 minutes and air-dried. After blocking in PBS, 10% goat serum (Sigma), 0.1% Tween-20 for 1 hour at room temperature, samples were incubated in blocking solution overnight at 4°C with primary antibodies, followed by 1 hour at room temperature with fluorescent secondary antibodies. For actin staining, Alexa Fluor-488-phalloidin (Molecular Probes) was used for 20 min at room temperature, using a 1:21 dilution in blocking solution. Nuclei were counterstained with 10 µg/ml propidium iodide (Sigma). Washes between antibody incubations were 3x10 minutes in PBS. Samples were mounted in Vectashield mounting media (Vector Laboratories) with glass coverslips.
Microscopy
Immunofluorescent images were obtained with a Nikon Eclipse TE2000-U inverted microscope, Photometrics CoolSNAP HQ camera, MetaMorph 6.1r1 software (Universal Imaging Corporation), and a Nikon Plan Ph1 DL 20x objective (0.40 NA) (Fig. 4C inset obtained with Nikon Plan Apo DIC H 60x oil objective of 1.40 NA). Confocal images were obtained with the same microscope and a Nikon D-Eclipse C1 confocal attachment, Nikon EZ-C1 2.10 software, channel series setup, and the 60x oil objective. Images were cropped and adjusted for contrast using Adobe Photoshop 7.
Western blots
Cell extracts were prepared in 62.6 mM Tris-HCl, pH 6.8, 2% SDS, 5% glycerol, 5 µg/ml pepstatin (Sigma), 500 µM AEBSF, 150 nM aprotinin, 1 µM E-64, 0.5 mM EDTA, 1 µM leupeptin (all from Calbiochem) and measured using the Lowry protein assay (Peterson, 1977
). SDS-PAGE was performed under reducing conditions using equal amounts of protein and 4-12% or 4-20% polyacrylamide Tris-glycine gradient gels. Proteins were electrophoretically transferred to Immobilon-P membranes (Millipore). Blots were blocked in 5% non-fat dry milk in TBS-T (50 mM Tris-HCl pH 7.4, 100 mM NaCl, 0.1% Tween-20) for 1 hour at room temperature, followed by incubation in blocking buffer overnight at 4°C with primary antibodies, then 1 hour at room temperature, with HRP-conjugated secondary antibodies.. Blots were washed in TBS-T after antibody incubations, and bands were visualized with the ECL/ECL Plus systems (Amersham Pharmacia).
Antibodies
Mouse monoclonal antibodies (mAbs) specific for C-terminal ß-DG (NCL-b-DG; Novocastra), N-terminal ß-DG (BD Biosciences), E-cadherin (BD Transduction Labs) and ß-casein (Kaetzel and Ray, 1984
) were used for immunoblotting at 1:200, 1:500, 1:5000 and 1:2000, respectively. The former antibody was used for immunostaining at 1:50. Rabbit polyclonal Abs (pAbs) specific for ZO-1 (Zymed) or laminin purified from the BM of Engelbreth-Holm-Swarm (EHS) mouse sarcoma (Sigma) were used for immunostaining at 1:100 and 1:40, respectively. Rat mAb GoH3 specific for
6 integrin (Chemicon) was used for immunostaining at 1:30. Mouse IgM mAb IIH6C4 specific for
-DG (Ervasti and Campbell, 1991
) (Upstate, Inc.) was used for immunostaining at 1:200 and immunoblotting at 1:300. Function blocking antibodies for
6- and ß1-integrins were used at 10 and 50 µg/ml, respectively (PharMingen). The anti-
6 integrin antibody was later tested at 100 µg/ml, and produced the same result.
Cy5-, FITC- or Rhodamine-conjugated, affinity-absorbed antibodies specific for mouse, rat or rabbit IgG and mouse IgM (Amersham Pharmacia; Chemicon; Caltag) were used at a 1:50 dilution. HRP-conjugated antibodies specific for mouse IgG (Amersham Pharmacia) and mouse IgM (Sigma) were used for western blots at 1:2000 and 1:3000, respectively.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Aumailley, M., Bruckner-Tuderman, L., Carter, W. G., Deutzmann, R., Edgar, D., Ekblom, P., Engel, J., Engvall, E., Hohenester, E., Jones, J. C. et al. (2005). A simplified laminin nomenclature. Matrix Biol. 24, 326-332.[CrossRef][Medline]
Cohn, R. D., Henry, M. D., Michele, D. E., Barresi, R., Saito, F., Moore, S. A., Flanagan, J. D., Skwarchuk, M. W., Robbins, M. E., Mendell, J. R. et al. (2002). Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell 110, 639-648.[CrossRef][Medline]
Colognato, H., Winkelmann, D. A. and Yurchenco, P. D. (1999). Laminin polymerization induces a receptor-cytoskeleton network. J. Cell Biol. 145, 619-631.
Deng, W. M., Schneider, M., Frock, R., Castillejo-Lopez, C., Gaman, E. A., Baumgartner, S. and Ruohola-Baker, H. (2003). Dystroglycan is required for polarizing the epithelial cells and the oocyte in Drosophila. Development 130, 173-184.
Driss, A., Charrier, L., Yan, Y., Nduati, V., Sitaraman, S. and Merlin, D. (2005). Dystroglycan receptor is involved in integrin activation in intestinal epithelia. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G1228-G1242.[Medline]
Durbeej, M. and Campbell, K. P. (2002). Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr. Opin. Genet. Dev. 12, 349-361.[CrossRef][Medline]
Durbeej, M., Larsson, E., Ibraghimov, B. O., Roberds, S. L., Campbell, K. P. and Ekblom, P. (1995). Non-muscle alpha-dystroglycan is involved in epithelial development. J. Cell Biol. 130, 79-91.
Durbeej, M., Henry, M. D., Ferletta, M., Campbell, K. P. and Ekblom, P. (1998). Distribution of dystroglycan in normal adult mouse tissues. J. Histochem. Cytochem. 46, 449-457.
Durbeej, M., Talts, J. F., Henry, M. D., Yurchenco, P. D., Campbell, K. P. and Ekblom, P. (2001). Dystroglycan binding to laminin alpha1LG4 module influences epithelial morphogenesis of salivary gland and lung in vitro. Differentiation 69, 121-134.[CrossRef][Medline]
Ervasti, J. M. and Campbell, K. P. (1991). Membrane organization of the dystrophin-glycoprotein complex. Cell 66, 1121-1131.[CrossRef][Medline]
Ervasti, J. M. and Campbell, K. P. (1993). A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122, 809-823.
Faraldo, M. M., Deugnier, M. A., Lukashev, M., Thiery, J. P. and Glukhova, M. A. (1998). Perturbation of beta1-integrin function alters the development of murine mammary gland. EMBO J. 17, 2139-2147.[CrossRef][Medline]
Gee, S. H., Blacher, R. W., Douville, P. J., Provost, P. R., Yurchenco, P. D. and Carbonetto, S. (1993). Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin. J. Biol. Chem. 268, 14972-14980.
Gudjonsson, T., Ronnov-Jessen, L., Villadsen, R., Rank, F., Bissell, M. J. and Petersen, O. W. (2002). Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J. Cell Sci. 115, 39-50.
Henry, M. D. and Campbell, K. P. (1998). A role for dystroglycan in basement membrane assembly. Cell 95, 859-870.[CrossRef][Medline]
Henry, M. D., Cohen, M. B. and Campbell, K. P. (2001a). Reduced expression of dystroglycan in breast and prostate cancer. Hum. Pathol. 32, 791-795.[CrossRef][Medline]
Henry, M. D., Satz, J. S., Brakebusch, C., Costell, M., Gustafsson, E., Fassler, R. and Campbell, K. P. (2001b). Distinct roles for dystroglycan, ß1 integrin and perlecan in cell surface laminin organization. J. Cell Sci. 114, 1137-1144.[Abstract]
Ibraghimov-Beskrovnaya, O., Ervasti, J. M., Leveille, C. J., Slaughter, C. A., Sernett, S. W. and Campbell, K. P. (1992). Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355, 696-702.[CrossRef][Medline]
Ilsley, J. L., Sudol, M. and Winder, S. J. (2002). The WW domain: linking cell signalling to the membrane cytoskeleton. Cell. Signal. 14, 183-189.[CrossRef][Medline]
Kaetzel, C. S. and Ray, D. B. (1984). Immunochemical characterization with monoclonal antibodies of three major caseins and alpha-lactalbumin from rat milk. J. Dairy Sci. 67, 64-75.
Kemler, R., Brulet, P., Schnebelen, M. T., Gaillard, J. and Jacob, F. (1981). Reactivity of monoclonal antibodies against intermediate filament proteins during embryonic development. J. Embryol. Exp. Morphol. 64, 45-60.[Medline]
Kinoshita, S., Su, L., Amano, M., Timmerman, L. A., Kaneshima, H. and Nolan, G. P. (1997). The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. Immunity 6, 235-244.[CrossRef][Medline]
Kittrell, F. S., Oborn, C. J. and Medina, D. (1992). Development of mammary preneoplasias in vivo from mouse mammary epithelial cell lines in vitro. Cancer Res. 52, 1924-1932.
Li, S., Harrison, D., Carbonetto, S., Fassler, R., Smyth, N., Edgar, D. and Yurchenco, P. D. (2002). Matrix assembly, regulation, and survival functions of laminin and its receptors in embryonic stem cell differentiation. J. Cell Biol. 157, 1279-1290.
Li, S., Edgar, D., Fassler, R., Wadsworth, W. and Yurchenco, P. D. (2003). The role of laminin in embryonic cell polarization and tissue organization. Dev. Cell 4, 613-624.[CrossRef][Medline]
Li, S., Liquari, P., McKee, K. K., Harrison, D., Patel, R., Lee, S. and Yurchenco, P. D. (2005). Laminin-sulfatide binding initiates basement membrane assembly and enables receptor signaling in Schwann cells and fibroblasts. J. Cell Biol. 169, 179-189.
Lohikangas, L., Gullberg, D. and Johansson, S. (2001). Assembly of laminin polymers is dependent on beta1-integrins. Exp. Cell Res. 265, 135-144.[CrossRef][Medline]
Losasso, C., Di Tommaso, F., Sgambato, A., Ardito, R., Cittadini, A., Giardina, B., Petrucci, T. C. and Brancaccio, A. (2000). Anomalous dystroglycan in carcinoma cell lines. FEBS Lett. 484, 194-198.[CrossRef][Medline]
Michele, D. E. and Campbell, K. P. (2003). Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J. Biol. Chem. 278, 15457-15460.
Michele, D. E., Barresi, R., Kanagawa, M., Saito, F., Cohn, R. D., Satz, J. S., Dollar, J., Nishino, I., Kelley, R. I., Somer, H. et al. (2002). Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418, 417-422.[CrossRef][Medline]
Miner, J. H. and Yurchenco, P. D. (2004). Laminin functions in tissue morphogenesis. Annu. Rev. Cell Dev. Biol. 20, 255-284.[CrossRef][Medline]
Moore, S. A., Saito, F., Chen, J., Michele, D. E., Henry, M. D., Messing, A., Cohn, R. D., Ross-Barta, S. E., Westra, S., Williamson, R. A. et al. (2002). Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 418, 422-425.[CrossRef][Medline]
Moss, M. L., Jin, S. L., Milla, M. E., Bickett, D. M., Burkhart, W., Carter, H. L., Chen, W. J., Clay, W. C., Didsbury, J. R., Hassler, D. et al. (1997). Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385, 733-736.[CrossRef][Medline]
Muschler, J., Lochter, A., Roskelley, C. D., Yurchenco, P. and Bissell, M. J. (1999). Division of labor among the alpha6beta4 integrin, beta1 integrins, and an E3 laminin receptor to signal morphogenesis and beta-casein expression in mammary epithelial cells. Mol. Biol. Cell 10, 2817-2828.
Muschler, J., Levy, D., Boudreau, R., Henry, M., Campbell, K. and Bissell, M. J. (2002). A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells. Cancer Res. 62, 7102-7109.
Naylor, M. J., Li, N., Cheung, J., Lowe, E. T., Lambert, E., Marlow, R., Wang, P., Schatzmann, F., Wintermantel, T., Schuetz, G. et al. (2005). Ablation of beta1 integrin in mammary epithelium reveals a key role for integrin in glandular morphogenesis and differentiation. J. Cell Biol. 171, 717-728.
Patarroyo, M., Tryggvason, K. and Virtanen, I. (2002). Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin. Cancer Biol. 12, 197-207.[CrossRef][Medline]
Pawson, T. (2004). Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell 116, 191-203.[CrossRef][Medline]
Peterson, G. L. (1977). A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83, 346-356.[CrossRef][Medline]
Sambrook, J., Fritsch, E. F. and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory.
Scheele, S., Falk, M., Franzen, A., Ellin, F., Ferletta, M., Lonaio, P., Andersson, B., Timpl, R., Forsberg, E. and Ekblom, P. (2005). Laminin alpha1 globular domains 4-5 induce fetal development but are not vital for embryonic basement membrane assembly. Proc. Natl. Acad. Sci. USA 102, 1502-1506.
Sgambato, A., Migaldi, M., Montanari, M., Camerini, A., Brancaccio, A., Rossi, G., Cangiano, R., Losasso, C., Capelli, G., Trentini, G. P. et al. (2003). Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. Am. J. Pathol. 162, 849-860.
Sgambato, A., Di Salvatore, M. A., De Paola, B., Rettino, A., Faraglia, B., Boninsegna, A., Graziani, C., Camerini, A., Proietti, G. and Cittadini, A. (2006). Analysis of dystroglycan regulation and functions in mouse mammary epithelial cells and implications for mammary tumorigenesis. J. Cell Physiol. 207, 520-529.[CrossRef][Medline]
Singh, J., Itahana, Y., Knight-Krajewski, S., Kanagawa, M., Campbell, K. P., Bissell, M. J. and Muschler, J. (2004). Proteolytic enzymes and altered glycosylation modulate dystroglycan function in carcinoma cells. Cancer Res. 64, 6152-6159.
Slade, M. J., Coope, R. C., Gomm, J. J. and Coombes, R. C. (1999). The human mammary gland basement membrane is integral to the polarity of luminal epithelial cells. Exp. Cell Res. 247, 267-278.[CrossRef][Medline]
Sotgia, F., Lee, H., Bedford, M. T., Petrucci, T., Sudol, M. and Lisanti, M. P. (2001). Tyrosine phosphorylation of beta-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins. Biochemistry 40, 14585-14592.[CrossRef][Medline]
Streuli, C. H., Bailey, N. and Bissell, M. J. (1991). Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity. J. Cell Biol. 115, 1383-1395.
Streuli, C. H., Schmidhauser, C., Bailey, N., Yurchenco, P., Skubitz, A. P., Roskelley, C. and Bissell, M. J. (1995). Laminin mediates tissue-specific gene expression in mammary epithelia. J. Cell Biol. 129, 591-603.
Weaver, V. M., Petersen, O. W., Wang, F., Larabell, C. A., Briand, P., Damsky, C. and Bissell, M. J. (1997). Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 137, 231-245.
Weir, M. L. and Muschler, J. (2003). Dystroglycan: emerging roles in mammary gland function. J. Mammary Gland Biol. Neoplasia 8, 409-419.[CrossRef][Medline]
Williamson, R. A., Henry, M. D., Daniels, K. J., Hrstka, R. F., Lee, J. C., Sunada, Y., Ibraghimov, B. O. and Campbell, K. P. (1997). Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Hum. Mol. Genet. 6, 831-841.
Yang, B., Jung, D., Motto, D., Meyer, J., Koretzky, G. and Campbell, K. P. (1995). SH3 domain-mediated interaction of dystroglycan and Grb2. J. Biol. Chem. 270, 11711-11714.
Yeaman, C., Grindstaff, K. K. and Nelson, W. J. (1999). New perspectives on mechanisms involved in generating epithelial cell polarity. Physiol. Rev. 79, 73-98.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
M. Masuda-Hirata, A. Suzuki, Y. Amano, K. Yamashita, M. Ide, T. Yamanaka, M. Sakai, M. Imamura, and S. Ohno Intracellular polarity protein PAR-1 regulates extracellular laminin assembly by regulating the dystroglycan complex Genes Cells, July 1, 2009; 14(7): 835 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B.-V. de Bernabe, K.-i. Inamori, T. Yoshida-Moriguchi, C. J. Weydert, H. A. Harper, T. Willer, M. D. Henry, and K. P. Campbell Loss of {alpha}-Dystroglycan Laminin Binding in Epithelium-derived Cancers Is Caused by Silencing of LARGE J. Biol. Chem., April 24, 2009; 284(17): 11279 - 11284. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. McKee, S. Capizzi, and P. D. Yurchenco Scaffold-forming and Adhesive Contributions of Synthetic Laminin-binding Proteins to Basement Membrane Assembly J. Biol. Chem., March 27, 2009; 284(13): 8984 - 8994. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Xu, C. M. Nelson, J. L. Muschler, M. Veiseh, B. K. Vonderhaar, and M. J. Bissell Sustained activation of STAT5 is essential for chromatin remodeling and maintenance of mammary-specific function J. Cell Biol., January 12, 2009; 184(1): 57 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Akhavan, S. N. Crivelli, M. Singh, V. R. Lingappa, and J. L. Muschler SEA domain proteolysis determines the functional composition of dystroglycan FASEB J, February 1, 2008; 22(2): 612 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fujiwara, Y. Hayashi, N. Sanzen, R. Kobayashi, C. N. Weber, T. Emoto, S. Futaki, H. Niwa, P. Murray, D. Edgar, et al. Regulation of Mesodermal Differentiation of Mouse Embryonic Stem Cells by Basement Membranes J. Biol. Chem., October 5, 2007; 282(40): 29701 - 29711. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Yatsenko, E. E. Gray, H. R. Shcherbata, L. B. Patterson, V. D. Sood, M. M. Kucherenko, D. Baker, and H. Ruohola-Baker A Putative Src Homology 3 Domain Binding Motif but Not the C-terminal Dystrophin WW Domain Binding Motif Is Required for Dystroglycan Function in Cellular Polarity in Drosophila J. Biol. Chem., May 18, 2007; 282(20): 15159 - 15169. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Xu, V. A. Spencer, and M. J. Bissell Extracellular Matrix-regulated Gene Expression Requires Cooperation of SWI/SNF and Transcription Factors J. Biol. Chem., May 18, 2007; 282(20): 14992 - 14999. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Harrison, S.-A. Hussain, A. C. Combs, J. M. Ervasti, P. D. Yurchenco, and E. Hohenester Crystal Structure and Cell Surface Anchorage Sites of Laminin {alpha}1LG4-5 J. Biol. Chem., April 13, 2007; 282(15): 11573 - 11581. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||